Cargando…
Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin
BACKGROUND: ARDS and ALI are life-threatening diseases with extremely high mortality in patients. Different sources of MSCs could mitigate the symptoms of ALI from diverse mechanisms. Liraglutide is an activator of glucagon-like peptide-1 receptor (GLP-1R) that activates anti-apoptotic pathways and...
Autores principales: | Yang, Xiaotong, Ma, Xiaoying, Don, Ocholi, Song, Yuanlin, Chen, Xiaoyan, Liu, Jianwen, Qu, Jieming, Feng, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238586/ https://www.ncbi.nlm.nih.gov/pubmed/32429994 http://dx.doi.org/10.1186/s13287-020-01689-5 |
Ejemplares similares
-
Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway
por: Feng, Yun, et al.
Publicado: (2020) -
Retraction Note: Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway
por: Feng, Yun, et al.
Publicado: (2023) -
Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
por: Li, Zhengming, et al.
Publicado: (2019) -
Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway
por: Wang, Li, et al.
Publicado: (2019) -
Liraglutide relieves cardiac dilated function than DPP‐4 inhibitors
por: Hiramatsu, Takeyuki, et al.
Publicado: (2018)